United States
Germany
Japan
United Kingdom
China
BRAF Mutant (G466V), Myc-DDK-tagged ORF clone of Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF) as transfection-ready DNA
| Mutation | G466V |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
cDNA Clones
BRAF Mutant (S467A), Myc-DDK-tagged ORF clone of Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF) as transfection-ready DNA
| Mutation | S467A |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
BRAF Mutant (A246P), Myc-DDK-tagged ORF clone of Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF) as transfection-ready DNA
| Mutation | A246P |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
BRAF Mutant (E501v), Myc-DDK-tagged ORF clone of Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF) as transfection-ready DNA
| Mutation | E501v |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
BRAF Mutant (G534R), Myc-DDK-tagged ORF clone of Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF) as transfection-ready DNA
| Mutation | G534R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
BRAF Mutant (N580D), Myc-DDK-tagged ORF clone of Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF) as transfection-ready DNA
| Mutation | N580D |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Braf (untagged) - Mouse Braf transforming gene (Braf), (10ug)
| Type | Mouse Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
3' UTR clone of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
活动过滤器
优化搜索结果
Species
Vectors
Brands
Families
Pathways
- Acute myeloid leukemia (34)
- Bladder cancer (34)
- Chemokine signaling pathway (34)
- Chronic myeloid leukemia (34)
- Colorectal cancer (34)
- Endometrial cancer (34)
- ErbB signaling pathway (34)
- Focal adhesion (34)
- Glioma (34)
- Insulin signaling pathway (34)
- Long-term depression (34)
- Long-term potentiation (34)
- MAPK signaling pathway (34)
- Melanoma (34)
- Natural killer cell mediated cytotoxicity (34)
- Neurotrophin signaling pathway (34)
- Non-small cell lung cancer (34)
- Pancreatic cancer (34)
- Pathways in cancer (34)
- Progesterone-mediated oocyte maturation (34)
- Prostate cancer (34)
- Regulation of actin cytoskeleton (34)
- Renal cell carcinoma (34)
- Thyroid cancer (34)
- Vascular smooth muscle contraction (34)
- mTOR signaling pathway (34)
